Use of immunomodulating drugs and risk of cutaneous melanoma: A nationwide nested case-control study

dc.contributor.author	Berge, Leon Alexander
dc.contributor.author	Kulle, Bettina
dc.contributor.author	Stenehjem, Jo S.
dc.contributor.author	Heir, Trond
dc.contributor.author	Karlstad, Øystein
dc.contributor.author	Juzeniene, Asta
dc.contributor.author	Ghiasvand, Reza
dc.contributor.author	Larsen, Inger Kristin
dc.contributor.author	Green, Adele C.
dc.contributor.author	Veierød, Marit Bragelien
dc.contributor.author	Robsahm, Trude Eid
dc.date.accessioned	2023-05-08T10:28:32Z
dc.date.available	2023-05-08T10:28:32Z
dc.date.created	2021-01-19T17:29:13Z
dc.date.issued	2020
dc.identifier.citation	Clinical Epidemiology. 2020, 12 1389-1401.
dc.identifier.issn	1179-1349
dc.identifier.uri	https://hdl.handle.net/11250/3066890
dc.language.iso	eng
dc.title	Use of immunomodulating drugs and risk of cutaneous melanoma: A nationwide nested case-control study
dc.type	Peer reviewed
dc.type	Journal article
dc.description.version	publishedVersion
dc.source.pagenumber	1389-1401
dc.source.volume	12
dc.source.journal	Clinical Epidemiology
dc.identifier.doi	10.2147/CLEP.S269446
dc.identifier.cristin	1874694
cristin.ispublished	true
cristin.fulltext	original
cristin.qualitycode	1